Background of the Case
Former Philippine Health Secretary Francisco Duque III has announced plans to file a motion for reconsideration in response to the Ombudsman’s order to file graft charges against him and former budget undersecretary Christopher Lao. The charges relate to the alleged improper transfer of over P41 billion intended for the procurement of COVID-19 supplies.
Details of the Allegations
The controversy centers on the decision by the Department of Health (DOH) to transfer these funds to the Procurement Service-Department of Budget and Management (PS-DBM), which was headed by Lao at the time. The Ombudsman has declared this transfer unlawful, stating that the PS-DBM was only authorized to purchase common-use supplies and equipment (CSE), a category that did not include the pandemic-related supplies bought with the allocated funds.
Duque’s Defense
Duque, who also chaired the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-EID), defended the actions taken during his administration. He cited the use of a “whole of government approach” to quickly address the needs of the COVID-19 pandemic. Duque argued that the legal framework, including the Republic Act 9184, Bayanihan Laws, the General Appropriations Act, and Executive Order 359, provided a basis for their decisions. He emphasized that the transferred funds were properly documented and that the DOH maintained constant coordination with the PS-DBM.
Impact on Healthcare Workers
The former secretary highlighted the urgent need for personal protective equipment (PPE) during the pandemic, stating that waiting for local suppliers could have led to more deaths and the potential collapse of the Philippines’ healthcare system. Duque’s appeal is expected to address both the graft charges and the findings of grave misconduct, gross neglect of duty, and conduct prejudicial to the service, as determined by the Ombudsman in a separate administrative complaint.
Political and Public Reactions
The DOH has expressed its respect for the legal processes involved and has committed to acting accordingly. Meanwhile, Senator Risa Hontiveros, who played a significant role in bringing the issue to light through Blue Ribbon Committee hearings, welcomed the Ombudsman’s decision. Hontiveros emphasized that the development was a victory for the public, particularly healthcare workers who faced hardships due to delayed allowances while funds were allegedly misused.
Conclusion
As Duque prepares his legal challenge, the case continues to stir significant public and political debate, reflecting ongoing concerns over accountability and governance in the management of the pandemic response. The outcome of the appeal could have far-reaching implications for both the individuals involved and the broader political landscape.